- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Hypoxia to Improve Non–Small Cell Lung Cancer Outcome
Authors
Keywords
-
Journal
JNCI-Journal of the National Cancer Institute
Volume 110, Issue 1, Pages 14-30
Publisher
Oxford University Press (OUP)
Online
2017-07-06
DOI
10.1093/jnci/djx160
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oxygen-Enhanced MRI Is a Major Advance in Tumor Hypoxia Imaging
- (2016) M. W. Dewhirst et al. CANCER RESEARCH
- Hypoxia Potentiates the Radiation-Sensitizing Effect of Olaparib in Human Non-Small Cell Lung Cancer Xenografts by Contextual Synthetic Lethality
- (2016) Yanyan Jiang et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis
- (2016) Sheng-li Yang et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Prognostic significance of hypoxic PET using 18 F-FAZA and 62 Cu-ATSM in non-small-cell lung cancer
- (2016) Tomonari Kinoshita et al. LUNG CANCER
- Quantitative [18F]FMISO PET Imaging Shows Reduction of Hypoxia Following Trastuzumab in a Murine Model of HER2+ Breast Cancer
- (2016) Anna G. Sorace et al. MOLECULAR IMAGING AND BIOLOGY
- Clinical development of new drug–radiotherapy combinations
- (2016) Ricky A. Sharma et al. Nature Reviews Clinical Oncology
- Imaging biomarker roadmap for cancer studies
- (2016) James P. B. O'Connor et al. Nature Reviews Clinical Oncology
- Prognostic value of blood-biomarkers related to hypoxia, inflammation, immune response and tumour load in non-small cell lung cancer – A survival model with external validation
- (2016) Sara Carvalho et al. RADIOTHERAPY AND ONCOLOGY
- The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia
- (2016) Thomas M. Ashton et al. Nature Communications
- Protocol for the isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC): a feasibility study
- (2016) Kate Haslett et al. BMJ Open
- Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia
- (2016) Nicole E. Scharping et al. Cancer Immunology Research
- Reproducibility of 18F-fluoromisonidazole intratumour distribution in non-small cell lung cancer
- (2016) Milan Grkovski et al. EJNMMI Research
- An exploratory study of volumetric analysis for assessing tumor response with 18F-FAZA PET/CT in patients with advanced non-small-cell lung cancer (NSCLC)
- (2016) Gerald S. M. A. Kerner et al. EJNMMI Research
- A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial
- (2015) A. Davidson et al. ANNALS OF ONCOLOGY
- A randomized phase II study comparing paclitaxel–carboplatin–bevacizumab with or without nitroglycerin patches in patients with stage IV nonsquamous nonsmall-cell lung cancer: NVALT12 (NCT01171170)
- (2015) A.-M. C. Dingemans et al. ANNALS OF ONCOLOGY
- AKR1C3 is a biomarker of sensitivity to PR-104 in preclinical models of T-cell acute lymphoblastic leukemia
- (2015) D. Moradi Manesh et al. BLOOD
- Validation of functional imaging as a biomarker for radiation treatment response
- (2015) C Jentsch et al. BRITISH JOURNAL OF RADIOLOGY
- Parallel phase Ib studies of two schedules of buparlisib (BKM120) plus carboplatin and paclitaxel (q21 days or q28 days) for patients with advanced solid tumors
- (2015) David M. Hyman et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Oxygen-Enhanced MRI Accurately Identifies, Quantifies, and Maps Tumor Hypoxia in Preclinical Cancer Models
- (2015) J. P. B. O'Connor et al. CANCER RESEARCH
- Prognostic value of18F-fluoroazomycin arabinoside PET/CT in patients with advanced non-small-cell lung cancer
- (2015) Tsuneo Saga et al. CANCER SCIENCE
- Effects of metformin on survival outcomes of lung cancer patients with type 2 diabetes mellitus: a meta-analysis
- (2015) R.-H. Tian et al. Clinical & Translational Oncology
- Preclinical Assessment of Efficacy of Radiation Dose Painting Based on Intratumoral FDG-PET Uptake
- (2015) D. Trani et al. CLINICAL CANCER RESEARCH
- TH-302 in Combination with Radiotherapy Enhances the Therapeutic Outcome and Is Associated with Pretreatment [18F]HX4 Hypoxia PET Imaging
- (2015) S. G. J. A. Peeters et al. CLINICAL CANCER RESEARCH
- Repeatability of hypoxia PET imaging using [18F]HX4 in lung and head and neck cancer patients: a prospective multicenter trial
- (2015) Catharina M. L. Zegers et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion
- (2015) Wouter van Elmpt et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Metronomic vinorelbine: Anti-angiogenic activity in vitro in normoxic and severe hypoxic conditions, and severe hypoxia-induced resistance to its anti-proliferative effect with reversal by Akt inhibition
- (2015) L. MAVROEIDIS et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- A Comparative Study of the Hypoxia PET Tracers [18F]HX4, [18F]FAZA, and [18F]FMISO in a Preclinical Tumor Model
- (2015) Sarah G.J.A. Peeters et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
- (2015) Claudia Allemani et al. LANCET
- Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study
- (2015) Jeffrey D Bradley et al. LANCET ONCOLOGY
- IAEA-HypoX. A randomized multicenter study of the hypoxic radiosensitizer nimorazole concomitant with accelerated radiotherapy in head and neck squamous cell carcinoma
- (2015) Mohamed A. Hassan Metwally et al. RADIOTHERAPY AND ONCOLOGY
- PET-based dose painting in non-small cell lung cancer: Comparing uniform dose escalation with boosting hypoxic and metabolically active sub-volumes
- (2015) Aniek J.G. Even et al. RADIOTHERAPY AND ONCOLOGY
- Hypoxia as a Cause of Treatment Failure in Non–Small Cell Carcinoma of the Lung
- (2015) Odd Terje Brustugun SEMINARS IN RADIATION ONCOLOGY
- Tumor Hypoxia Response After Targeted Therapy in EGFR-Mutant Non-Small Cell Lung Cancer
- (2015) Nils D. Arvold et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Circulating microRNA Biomarkers as Liquid Biopsy for Cancer Patients: Pros and Cons of Current Assays
- (2015) Shigeshi Ono et al. Journal of Clinical Medicine
- Prognostic Impact of Hypoxia-InduciblemiRNA-210in Patients with Lung Adenocarcinoma
- (2015) Jun Osugi et al. Journal of Oncology
- Defining normoxia, physoxia and hypoxia in tumours—implications for treatment response
- (2014) S R McKeown BRITISH JOURNAL OF RADIOLOGY
- In Vivo Quantification of Hypoxic and Metabolic Status of NSCLC Tumors Using [18F]HX4 and [18F]FDG-PET/CT Imaging
- (2014) C. M. L. Zegers et al. CLINICAL CANCER RESEARCH
- Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome
- (2014) J. P. B. O'Connor et al. CLINICAL CANCER RESEARCH
- The Meaning, Measurement and Modification of Hypoxia in the Laboratory and the Clinic
- (2014) E.M. Hammond et al. CLINICAL ONCOLOGY
- A prospective clinical study of 18 F-FAZA PET-CT hypoxia imaging in head and neck squamous cell carcinoma before and during radiation therapy
- (2014) Stéphanie Servagi-Vernat et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The Tumor Radiobiology of SRS and SBRT: Are More Than the 5 Rs Involved?
- (2014) J. Martin Brown et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium
- (2014) Erik O. Pettersen et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Parametric Methods for Quantification of 18F-FAZA Kinetics in Non-Small Cell Lung Cancer Patients
- (2014) E. E. Verwer et al. JOURNAL OF NUCLEAR MEDICINE
- Membrane Carbonic Anhydrase IX Expression and Relapse Risk in Resected Stage I–II Non–Small-Cell Lung Cancer
- (2014) David J. Stewart et al. Journal of Thoracic Oncology
- Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
- (2014) Emilie Lalonde et al. LANCET ONCOLOGY
- Randomized, double-blind phase II study to compare nitroglycerin plus oral vinorelbine plus cisplatin with oral vinorelbine plus cisplatin alone in patients with stage IIIB/IV non-small cell lung cancer (NSCLC)
- (2014) N. Reinmuth et al. LUNG CANCER
- Hypoxia Increases Gefitinib-Resistant Lung Cancer Stem Cells through the Activation of Insulin-Like Growth Factor 1 Receptor
- (2014) Akiko Murakami et al. PLoS One
- A pilot ‘window of opportunity’ neoadjuvant study of metformin in localised prostate cancer
- (2014) A M Joshua et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Dynamics of tumor hypoxia assessed by 18F-FAZA PET/CT in head and neck and lung cancer patients during chemoradiation: Possible implications for radiotherapy treatment planning strategies
- (2014) Vikram R. Bollineni et al. RADIOTHERAPY AND ONCOLOGY
- Phase II study. Concurrent chemotherapy and radiotherapy with nitroglycerin in locally advanced non-small cell lung cancer
- (2014) Oscar Arrieta et al. RADIOTHERAPY AND ONCOLOGY
- Prognostic Role of Hypoxic Inducible Factor Expression in Non-small Cell Lung Cancer: A Meta-analysis
- (2013) Cong Li et al. Asian Pacific Journal of Cancer Prevention
- A 26-Gene Hypoxia Signature Predicts Benefit from Hypoxia-Modifying Therapy in Laryngeal Cancer but Not Bladder Cancer
- (2013) A. Eustace et al. CLINICAL CANCER RESEARCH
- Reprogramming Metabolism with Metformin Improves Tumor Oxygenation and Radiotherapy Response
- (2013) V. E. Zannella et al. CLINICAL CANCER RESEARCH
- Pharmacokinetic analysis of [18F]FAZA in non-small cell lung cancer patients
- (2013) Eline E. Verwer et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prognostic significance of serum microRNA-210 levels in nonsmall-cell lung cancer
- (2013) Zhi-Hong Li et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Imaging of hypoxia with18F-FAZA PET in patients with locally advanced non-small cell lung cancer treated with definitive chemoradiotherapy
- (2013) Mateya E Trinkaus et al. Journal of Medical Imaging and Radiation Oncology
- Interobserver Agreement of Qualitative Analysis and Tumor Delineation of 18F-Fluoromisonidazole and 3'-Deoxy-3'-18F-Fluorothymidine PET Images in Lung Cancer
- (2013) S. Thureau et al. JOURNAL OF NUCLEAR MEDICINE
- Positive prognostic impact of miR-210 in non-small cell lung cancer
- (2013) Marte Eilertsen et al. LUNG CANCER
- Noninvasive tumor hypoxia measurement using magnetic resonance imaging in murine U87 glioma xenografts and in patients with glioblastoma
- (2013) Inna V. Linnik et al. MAGNETIC RESONANCE IN MEDICINE
- Computed 88% TCP dose for SBRT of NSCLC from tumour hypoxia modelling
- (2013) Ruggero Ruggieri et al. PHYSICS IN MEDICINE AND BIOLOGY
- Hypoxia imaging with [18F]HX4 PET in NSCLC patients: Defining optimal imaging parameters
- (2013) Catharina M.L. Zegers et al. RADIOTHERAPY AND ONCOLOGY
- Interaction of EGFR with the tumour microenvironment: Implications for radiation treatment
- (2013) Monique M. Nijkamp et al. RADIOTHERAPY AND ONCOLOGY
- MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines
- (2013) S Grosso et al. Cell Death & Disease
- Bioreductive prodrugs as cancer therapeutics: targeting tumor hypoxia
- (2013) Christopher P. Guise et al. Chinese Journal of Cancer
- PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours
- (2012) Mark J McKeage et al. BMC CANCER
- Targeting radiation-resistant hypoxic tumour cells through ATR inhibition
- (2012) I M Pires et al. BRITISH JOURNAL OF CANCER
- Hypoxia induces gefitinib resistance in non-small-cell lung cancer with both mutant and wild-type epidermal growth factor receptors
- (2012) Kunihiko Minakata et al. CANCER SCIENCE
- Prospective technical validation and assessment of intra-tumour heterogeneity of a low density array hypoxia gene profile in head and neck squamous cell carcinoma
- (2012) Guy N.J. Betts et al. EUROPEAN JOURNAL OF CANCER
- Elusive Goal of Targeting Tumor Hypoxia for Therapeutic Gain
- (2012) Lester Peters et al. JOURNAL OF CLINICAL ONCOLOGY
- Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis
- (2012) Sashendra Senthi et al. LANCET ONCOLOGY
- Promise and pitfalls of quantitative imaging in oncology clinical trials
- (2012) Brenda F. Kurland et al. MAGNETIC RESONANCE IMAGING
- A modified hypoxia-based TCP model to investigate the clinical outcome of stereotactic hypofractionated regimes for early stage non-small-cell lung cancer (NSCLC)
- (2012) L. Strigari et al. MEDICAL PHYSICS
- Hypoxia-activated prodrugs forge ahead in cancer
- (2012) Jim Kling NATURE BIOTECHNOLOGY
- Imaging hypoxia to improve radiotherapy outcome
- (2012) Michael R. Horsman et al. Nature Reviews Clinical Oncology
- Predicting outcomes in radiation oncology—multifactorial decision support systems
- (2012) Philippe Lambin et al. Nature Reviews Clinical Oncology
- Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer
- (2012) Daniel Zips et al. RADIOTHERAPY AND ONCOLOGY
- FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: Results from the DAHANCA 24 trial
- (2012) Lise Saksø Mortensen et al. RADIOTHERAPY AND ONCOLOGY
- The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer
- (2012) Wouter van Elmpt et al. RADIOTHERAPY AND ONCOLOGY
- Hypoxia Gene Expression Signatures as Prognostic and Predictive Markers in Head and Neck Radiotherapy
- (2012) Kasper Toustrup et al. SEMINARS IN RADIATION ONCOLOGY
- Hypoxia-induced cisplatin resistance is reversible and growth rate independent in lung cancer cells
- (2011) Christoph Wohlkoenig et al. CANCER LETTERS
- Development of a Hypoxia Gene Expression Classifier with Predictive Impact for Hypoxic Modification of Radiotherapy in Head and Neck Cancer
- (2011) K. Toustrup et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Prognostic Significance of Plasma Osteopontin in Patients with Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Treated on TROG 02.02 Phase III Trial
- (2011) A. M. Lim et al. CLINICAL CANCER RESEARCH
- Selective Tumor Hypoxia Targeting by Hypoxia-Activated Prodrug TH-302 Inhibits Tumor Growth in Preclinical Models of Cancer
- (2011) J. D. Sun et al. CLINICAL CANCER RESEARCH
- Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of TH-302, a Hypoxia-Activated Prodrug, in Patients with Advanced Solid Malignancies
- (2011) G. J. Weiss et al. CLINICAL CANCER RESEARCH
- Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways
- (2011) Nadine Rohwer et al. DRUG RESISTANCE UPDATES
- Trends in incidence of small cell lung cancer and all lung cancer
- (2011) Sharma P. Riaz et al. LUNG CANCER
- Dynamic contrast-enhanced-MRI of tumor hypoxia
- (2011) Tormod A.M. Egeland et al. MAGNETIC RESONANCE IN MEDICINE
- Bring on the biomarkers
- (2011) George Poste NATURE
- Assessment of hypoxia and radiation response in intramuscular experimental tumors by dynamic contrast-enhanced magnetic resonance imaging
- (2011) Kirsti Marie Øvrebø et al. RADIOTHERAPY AND ONCOLOGY
- High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer
- (2010) M İlie et al. BRITISH JOURNAL OF CANCER
- Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene
- (2010) F M Buffa et al. BRITISH JOURNAL OF CANCER
- Modulating the tumor microenvironment to increase radiation responsiveness
- (2010) Jayashree Karar et al. CANCER BIOLOGY & THERAPY
- Contextual Synthetic Lethality of Cancer Cell Kill Based on the Tumor Microenvironment
- (2010) N. Chan et al. CANCER RESEARCH
- Comparison of 18F-Fluoroerythronitroimidazole and 18F-Fluorodeoxyglucose Positron Emission Tomography and Prognostic Value in Locally Advanced Non–Small-Cell Lung Cancer
- (2010) Ling Li et al. Clinical Lung Cancer
- Ionizing Radiation Activates AMP-Activated Kinase (AMPK): A Target for Radiosensitization of Human Cancer Cells
- (2010) Toran Sanli et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Effect of chronic intermittent hypoxia on biological behavior and hypoxia-associated gene expression in lung cancer cells
- (2010) Yonglei Liu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Tirapazamine, Cisplatin, and Radiation Versus Cisplatin and Radiation for Advanced Squamous Cell Carcinoma of the Head and Neck (TROG 02.02, HeadSTART): A Phase III Trial of the Trans-Tasman Radiation Oncology Group
- (2010) Danny Rischin et al. JOURNAL OF CLINICAL ONCOLOGY
- Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
- (2010) Anne Aupérin et al. JOURNAL OF CLINICAL ONCOLOGY
- Serum Osteopontin Levels are Highly Prognostic for Survival in Advanced Non-small Cell Lung Cancer: Results from JMTO LC 0004
- (2010) Shun-Ichi Isa et al. Journal of Thoracic Oncology
- How to improve R&D productivity: the pharmaceutical industry's grand challenge
- (2010) Steven M. Paul et al. NATURE REVIEWS DRUG DISCOVERY
- Simultaneous positron emission tomography (PET) assessment of metabolism with 18F-fluoro-2-deoxy-d-glucose (FDG), proliferation with 18F-fluoro-thymidine (FLT), and hypoxia with 18fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): A pilot study
- (2010) Pierre Vera et al. RADIOTHERAPY AND ONCOLOGY
- Initial results of hypoxia imaging using 1-α-d-(5-deoxy-5-[18F]-fluoroarabinofuranosyl)-2-nitroimidazole (18F-FAZA)
- (2009) Ernst J. Postema et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Preliminary Study of Oxygen-Enhanced Longitudinal Relaxation in MRI: A Potential Novel Biomarker of Oxygenation Changes in Solid Tumors
- (2009) James P.B. O'Connor et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Prospective Trial Incorporating Pre-/Mid-Treatment [18F]-Misonidazole Positron Emission Tomography for Head-and-Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy
- (2009) Nancy Lee et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Pathophysiologic Correlation Between 62Cu-ATSM and 18F-FDG in Lung Cancer
- (2009) T. G. Lohith et al. JOURNAL OF NUCLEAR MEDICINE
- Dose Painting in Radiotherapy for Head and Neck Squamous Cell Carcinoma: Value of Repeated Functional Imaging with 18F-FDG PET, 18F-Fluoromisonidazole PET, Diffusion-Weighted MRI, and Dynamic Contrast-Enhanced MRI
- (2009) P. Dirix et al. JOURNAL OF NUCLEAR MEDICINE
- Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy 18Fluorodeoxyglucose-PET-CT scan
- (2009) Hugo J.W.L. Aerts et al. RADIOTHERAPY AND ONCOLOGY
- A Phase 1 Open-Label, Accelerated Dose-Escalation Study of the Hypoxia-Activated Prodrug AQ4N in Patients with Advanced Malignancies
- (2008) K. P. Papadopoulos et al. CLINICAL CANCER RESEARCH
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Lower Osteopontin Plasma Levels Are Associated With Superior Outcomes in Advanced Non–Small-Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy: SWOG Study S0003
- (2008) Philip C. Mack et al. JOURNAL OF CLINICAL ONCOLOGY
- Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole
- (2008) Rumi Murata et al. RADIOTHERAPY AND ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started